Lupus anticoagulant, thrombosis, and death

In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.

Saved in:
Bibliographic Details
Published in:Blood 2015-05, Vol.125 (22), p.3371-3372
Main Author: Diz-Küçükkaya, Reyhan
Format: Article
Language:English
Subjects:
Antiphospholipid Syndrome - mortality
Female
Humans
Lupus Coagulation Inhibitor - blood
Male
Pregnancy
Thrombosis - mortality
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3
cites cdi_FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3
container_end_page 3372
container_issue 22
container_start_page 3371
container_title Blood
container_volume 125
creator Diz-Küçükkaya, Reyhan
description In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.
doi_str_mv 10.1182/blood-2015-04-638320
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1684431434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120315986</els_id><sourcerecordid>1684431434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMo7rr6DUT2KLLRSZq06UWQxX-w4EXPIU2nbqQ1a9IKfnuzdvXoaQbmvZl5P0JOGVwypvhV1XpfUw5MUhA0z1TGYY9MmeSKAnDYJ1MAyKkoCzYhRzG-ATCRcXlIJjwHzkHyKblYDZshzs1776w3r0ObusW8XwffVT66uEijel6j6dfH5KAxbcSTXZ2Rl7vb5-UDXT3dPy5vVtQKUD3FLDM8GSSqWllelqbIVYFNw6WssCmhLAsDDErkXIJRommssawyvLK2sJjNyPm4dxP8x4Cx152LFtv0GvohapYrIbIURSSpGKU2-BgDNnoTXGfCl2agt5T0DyW9paRB6JFSsp3tLgxVh_Wf6RdLElyPAkw5Px0GHa3Dd4u1C2h7XXv3_4Vvo654TQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1684431434</pqid></control><display><type>article</type><title>Lupus anticoagulant, thrombosis, and death</title><source>Elsevier ScienceDirect Journals</source><creator>Diz-Küçükkaya, Reyhan</creator><creatorcontrib>Diz-Küçükkaya, Reyhan</creatorcontrib><description>In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.</description><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2015-04-638320</identifier><identifier>PMID: 26022052</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antiphospholipid Syndrome - mortality ; Female ; Humans ; Lupus Coagulation Inhibitor - blood ; Male ; Pregnancy ; Thrombosis - mortality</subject><ispartof>Blood, 2015-05, Vol.125 (22), p.3371-3372</ispartof><rights>2015 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3</citedby><cites>FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3</cites><orcidid>0000-0001-5814-7118</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120315986$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26022052$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diz-Küçükkaya, Reyhan</creatorcontrib><title>Lupus anticoagulant, thrombosis, and death</title><title>Blood</title><addtitle>Blood</addtitle><description>In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.</description><subject>Antiphospholipid Syndrome - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus Coagulation Inhibitor - blood</subject><subject>Male</subject><subject>Pregnancy</subject><subject>Thrombosis - mortality</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LxDAQxYMo7rr6DUT2KLLRSZq06UWQxX-w4EXPIU2nbqQ1a9IKfnuzdvXoaQbmvZl5P0JOGVwypvhV1XpfUw5MUhA0z1TGYY9MmeSKAnDYJ1MAyKkoCzYhRzG-ATCRcXlIJjwHzkHyKblYDZshzs1776w3r0ObusW8XwffVT66uEijel6j6dfH5KAxbcSTXZ2Rl7vb5-UDXT3dPy5vVtQKUD3FLDM8GSSqWllelqbIVYFNw6WssCmhLAsDDErkXIJRommssawyvLK2sJjNyPm4dxP8x4Cx152LFtv0GvohapYrIbIURSSpGKU2-BgDNnoTXGfCl2agt5T0DyW9paRB6JFSsp3tLgxVh_Wf6RdLElyPAkw5Px0GHa3Dd4u1C2h7XXv3_4Vvo654TQ</recordid><startdate>20150528</startdate><enddate>20150528</enddate><creator>Diz-Küçükkaya, Reyhan</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5814-7118</orcidid></search><sort><creationdate>20150528</creationdate><title>Lupus anticoagulant, thrombosis, and death</title><author>Diz-Küçükkaya, Reyhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antiphospholipid Syndrome - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus Coagulation Inhibitor - blood</topic><topic>Male</topic><topic>Pregnancy</topic><topic>Thrombosis - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diz-Küçükkaya, Reyhan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diz-Küçükkaya, Reyhan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lupus anticoagulant, thrombosis, and death</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2015-05-28</date><risdate>2015</risdate><volume>125</volume><issue>22</issue><spage>3371</spage><epage>3372</epage><pages>3371-3372</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><abstract>In this issue of Blood, Gebhart et al report a prospective observational cohort study evaluating 151 patients with persistently positive lupus anticoagulant (LA) for a median period of 8.2 years. They observed increased mortality in LA-positive patients, mainly due to new thrombotic events.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26022052</pmid><doi>10.1182/blood-2015-04-638320</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-5814-7118</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2015-05, Vol.125 (22), p.3371-3372
issn 0006-4971
1528-0020
language eng
recordid cdi_proquest_miscellaneous_1684431434
source Elsevier ScienceDirect Journals
subjects Antiphospholipid Syndrome - mortality
Female
Humans
Lupus Coagulation Inhibitor - blood
Male
Pregnancy
Thrombosis - mortality
title Lupus anticoagulant, thrombosis, and death
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lupus%20anticoagulant,%20thrombosis,%20and%20death&rft.jtitle=Blood&rft.au=Diz-K%C3%BC%C3%A7%C3%BCkkaya,%20Reyhan&rft.date=2015-05-28&rft.volume=125&rft.issue=22&rft.spage=3371&rft.epage=3372&rft.pages=3371-3372&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2015-04-638320&rft_dat=%3Cproquest_cross%3E1684431434%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-e33a2dea5e8d8c299a7687eff255bef90997a0109e2250a84ffcac1ba2bcc7ce3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1684431434&rft_id=info:pmid/26022052&rfr_iscdi=true